Fabio
90 lines
5.2 KiB
Markdown
90 lines
5.2 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11."
|
||
description: "Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11."
|
||
jurisdiction: "us/states/tn"
|
||
legislature: "Tennessee General Assembly"
|
||
session: "114"
|
||
identifier: "HB 1984"
|
||
citation: "Tennessee HB 1984 (114)"
|
||
classification: ["bill"]
|
||
subjects: ["Controlled Substances"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Hill"]
|
||
version_count: 1
|
||
action_count: 31
|
||
vote_count: 5
|
||
first_action: "2026-01-22"
|
||
last_action: "2026-04-24"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/e3159374-8a60-4419-b6e6-ebfb3f672914"
|
||
source_url: "https://wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB1984&ga=114"
|
||
source_hash: "296be32cf85c989fdf276ee11c0b47d94c1d7ed925ba84aabd9bb5ddd171f563"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-tn"]
|
||
---
|
||
|
||
# Tennessee HB 1984 (114) — Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Current Version** (committee substitute) — [source](https://capitol.tn.gov/Bills/114/Bill/HB1984.pdf)
|
||
|
||
## Votes
|
||
|
||
- FLOOR VOTE: Third Consideration 3/30/2026 Passed (1) — **28–3** (pass) · upper
|
||
- FLOOR VOTE: CONSENT CALENDAR PASSAGE ON THIRD CONSIDERATION 3/30/2026 Passed (1) — **82–1** (pass) · lower
|
||
- HOUSE HEALTH SUBCOMMITTEE: Rec. for pass by s/c ref. to Health Committee 2/18/2026 Passed (4) — **6–0** (pass) · lower
|
||
- HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Consent Calendar 3/26/2026 (2) — **0–0** (fail) · lower
|
||
- HOUSE HEALTH COMMITTEE: Rec. for pass; ref to Calendar & Rules Committee 3/17/2026 Passed (3) — **20–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Hill — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-01-22** Filed for introduction `filing`
|
||
- **2026-02-02** Intro., P1C. `introduction`
|
||
- **2026-02-04** Assigned to s/c Health Subcommittee `referral-committee`
|
||
- **2026-02-04** P2C, ref. to Health Committee `referral-committee`
|
||
- **2026-02-11** Placed on s/c cal Health Subcommittee for 2/18/2026
|
||
- **2026-02-11** Sponsor(s) withdrawn. `sponsorship`
|
||
- **2026-02-11** Sponsor change. `sponsorship`
|
||
- **2026-02-12** Sponsor(s) Added. `sponsorship`
|
||
- **2026-02-18** Rec. for pass by s/c ref. to Health Committee `committee-passage-favorable`
|
||
- **2026-02-25** Placed on cal. Health Committee for 3/3/2026
|
||
- **2026-02-25** Sponsor(s) Added. `sponsorship`
|
||
- **2026-03-03** Action def. in Health Committee to 3/10/2026
|
||
- **2026-03-04** Placed on cal. Health Committee for 3/10/2026
|
||
- **2026-03-10** No Action Taken
|
||
- **2026-03-11** Placed on cal. Health Committee for 3/17/2026
|
||
- **2026-03-17** Rec. for pass; ref to Calendar & Rules Committee `committee-passage-favorable`
|
||
- **2026-03-25** Placed on cal. Calendar & Rules Committee for 3/26/2026
|
||
- **2026-03-26** H. Placed on Consent Calendar for 3/30/2026
|
||
- **2026-03-30** Passed Senate, Ayes 28, Nays 3 `passage`
|
||
- **2026-03-30** Senate substituted House Bill for companion Senate Bill. `substitution`
|
||
- **2026-03-30** Received from House, Passed on First Consideration `introduction`
|
||
- **2026-03-30** Sponsor(s) Added. `sponsorship`
|
||
- **2026-03-30** Engrossed; ready for transmission to Sen. `receipt`
|
||
- **2026-03-30** Passed H., Ayes 82, Nays 1, PNV 10 `passage`
|
||
- **2026-04-01** Enrolled; ready for sig. of H. Speaker. `enrolled`
|
||
- **2026-04-06** Signed by Senate Speaker `passage`
|
||
- **2026-04-06** Signed by H. Speaker `passage`
|
||
- **2026-04-07** Transmitted to Governor for his action. `executive-receipt`
|
||
- **2026-04-16** Signed by Governor. `executive-signature`
|
||
- **2026-04-24** Effective date(s) 04/16/2026
|
||
- **2026-04-24** Pub. Ch. 753
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/e3159374-8a60-4419-b6e6-ebfb3f672914`. Confidence: reported (aggregated from official Tennessee legislature records).
|
||
|